- Clare Dyer, legal correspondent
- BMJ
The manufacturer of the sleeping pill triazolam (Halcion), banned from sale in the United Kingdom since 1993,has failed in its attempt to invoke European Community law to get the ban reconsidered.
The European Court of Justice in Luxembourg has held that the UK system for challenging drug bans by judicial review proceedings in the High Court complies with European Community law.
In judicial review …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.